Xeris Pharmaceuticals

  • Home
  • Xeris Pharmaceuticals

Xeris Pharmaceuticals We’re a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.

Pharmaceutical Company

What a week!​​We just got back from Children with Diabetes Friends for Life Orlando 2025 and our hearts are full. It was...
14/07/2025

What a week!​

We just got back from Children with Diabetes Friends for Life Orlando 2025 and our hearts are full. It was such an honor to spend time with so many inspiring children, adults, and families with . The energy, the support, the learning - it’s hard to put into words how special this event truly is.​

A huge thank you to Children with Diabetes for creating a space where connection, learning, and community come first. We’re so grateful to be a part of it, and we can’t wait to see you all again next year! Check out some of our favorite moments below.​

We’re excited to share that we’ll be at Children with Diabetes Friends for Life Orlando 2025 this July 8-13 in Orlando, ...
25/06/2025

We’re excited to share that we’ll be at Children with Diabetes Friends for Life Orlando 2025 this July 8-13 in Orlando, FL! This amazing event brings together children, teens, adults, and families living with for a week full of education, support, and community. Because, whether it’s your first time or your fifteenth, there’s truly nothing like the feeling of being surrounded by people who just get it.​

We’re passionate about making life with a little easier, and our team can’t wait to connect with families and caregivers, learn from medical experts and diabetes advocates, and share how we’re working to support better in daily life. If you’ll be at , please come say hi! We’d love to meet you, hear your story, and share what we’re working on to help make a difference.​

Every second counts in a   emergency. At Xeris, we are committed to supporting people living with   by providing solutio...
20/06/2025

Every second counts in a emergency. At Xeris, we are committed to supporting people living with by providing solutions that empower patients, caregivers, and healthcare providers with the confidence to treat swiftly in the face of a severe low.​

With this commitment at the forefront, we're excited to be at the 2025 American Diabetes Association , where we'll be connecting with people across the diabetes community, from patients to researchers to healthcare providers, to listen, learn, and share the latest in .​

Visit our website at https://bit.ly/3S0kCZe to learn more about our work in diabetes!​

We’re excited be attending the 2025 American Diabetes Association   this year!​​We look forward to connecting with the  ...
09/06/2025

We’re excited be attending the 2025 American Diabetes Association this year!​

We look forward to connecting with the community as we share our latest research and join the passionate leaders and innovators working to transform lives through science and care.​

20/05/2025

Even the people most experienced with can find themselves facing an unexpected emergency. This honest conversation from Dr. Pettus and Dr. Edelman is an important reminder of why being ready for a severe low matters. Thank you for sharing, TCOYD!​

We’ve teamed up with the American Diabetes Association to share helpful resources for recognizing and treating   emergen...
19/05/2025

We’ve teamed up with the American Diabetes Association to share helpful resources for recognizing and treating emergencies (also known as ). ​

If you or someone you love lives with , make sure you know what to do in the event of a severe low. Download the easy-to-understand infographic for information that could make all the difference: https://bit.ly/3S2GEuB.​

Hypoglycemia, or low blood glucose (blood sugar) levels, is a serious condition that leads to over 202,000 emergency department visits each year. To keep you and your loved ones safe, we’ve put together a new resource that covers the symptoms, prevention, and treatment of hypoglycemia. Download the infographic now and find other resources at bit.ly/4jtoLku.

  (CS) is a condition in which there is too much cortisol in your body. Elevated cortisol levels can affect your health ...
08/04/2025

(CS) is a condition in which there is too much cortisol in your body. Elevated cortisol levels can affect your health over time, impacting your bones, heart, ability to fight infection, and nervous system.​
​​​
On , help us honor the strength of the Cushing’s community ​​by learning more about this condition. Swipe through ➡️ for important facts about CS.​
​​​

We're taking a moment to share a big round of applause 👏 for our Regional Medical Affairs Directors (RMAD) on Internatio...
27/03/2025

We're taking a moment to share a big round of applause 👏 for our Regional Medical Affairs Directors (RMAD) on International Medical Science Liaison Day! These dedicated professionals engage with the medical and scientific community in discussions around the latest research and medical insights, furthering scientific understanding, and play a key role in the education of healthcare providers, helping to improve patient care and outcomes.​

Thank you to our RMAD team for all you do!​

Today is   ( )! ​​​​In partnership with Periodic Paralysis Association, we’re proud to be a lead sponsor of this importa...
23/03/2025

Today is ( )! ​​
​​
In partnership with Periodic Paralysis Association, we’re proud to be a lead sponsor of this important new awareness day spotlighting people living with ( ). ​​
​​
Join us today at 2 pm CT for a free webinar discussing raising awareness of PPP and building relationships within the PPP community: https://bit.ly/3D48Jh4. See you there! ​​
​​

We’re excited to share that we are a lead sponsor for the first ever   ( ), in partnership with Periodic Paralysis Assoc...
05/03/2025

We’re excited to share that we are a lead sponsor for the first ever ( ), in partnership with Periodic Paralysis Association! ​​
​​
Get involved with the ( ) community by joining our free webinar at 2 pm CT on March 23. Register today: https://bit.ly/3D48Jh4. ​​
​​

  is an important day in the   community – it’s an opportunity to raise awareness and share support for the more than 25...
28/02/2025

is an important day in the community – it’s an opportunity to raise awareness and share support for the more than 25-30 million people living with in the US. ​

You can learn more about our work with rare diseases like and ( ) – only two of the more than 6,000 diseases classified as “rare” – at our website: https://bit.ly/4aUnksc.

21/01/2025

🚨 Hypoglycemia, when your blood glucose (blood sugar) levels drop too low, leads to over 202,000 emergency department visits each year. 🚑 To keep you and your loved ones safe, the American Diabetes Association® and Xeris Pharmaceuticals® are teaming up to spread awareness on the importance of having lifesaving glucagon, preferably ready-to-use, for anyone with diabetes on insulin or at high-risk of hypoglycemia.

Read more at https://bit.ly/3WtOnEx.

Address


Alerts

Be the first to know and let us send you an email when Xeris Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Xeris Pharmaceuticals:

Shortcuts

  • Address
  • Alerts
  • Contact The Practice
  • Claim ownership or report listing
  • Want your practice to be the top-listed Clinic?

Share

About Xeris

Xeris is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. The company’s proprietary XeriSol™ and XeriJect™ formulation technologies allow for the subcutaneous (SC) and intramuscular (IM) delivery of highly concentrated, non-aqueous, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using syringes, auto-injectors, multi-dose pens, and infusion pumps. Xeris’ platforms have the potential to offer distinct advantages over existing formulations of marketed and development-stage products. In particular, XeriSol™ and XeriJect™ offer the opportunity to eliminate reconstitution, enable long-term room temperature stability, significantly reduce injection volume, and eliminate the requirement for intravenous (IV) infusion. These attributes can lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system.